However, since no difference in overall survival of AML patients with increased versus decreased expression of DICER1 in bone marrow was found [75], it was suggested that the influence of DICER1 expression on clinical outcomes may depend on the tissue of origin [75]. The gene discussed is DICER1; the disease is acute myeloid leukemia.